Early Experience With Eravacycline for Complicated Infections

Eravacycline (ERV) was used in 35 patients for various infections. The most common pathogen was Klebsiella pneumoniae, and 30-day survival was 74%. Absence of 30-day recurrence and resolution of signs and symptoms of infection were 91% and 57%, respectively. ERV was well-tolerated, with adverse even...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Alosaimy, Sara, Molina, Kyle C, Claeys, Kimberly C, Andrade, Justin, Truong, James, King, Madeline A, Pullinger, Benjamin M, Huang, Glen, Morrisette, Taylor, Lagnf, Abdalhamid M, Davis, Susan L, Rybak, Michael J
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Brief Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210802/
https://ncbi.nlm.nih.gov/pubmed/32411809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa071
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares